Trials / Completed
CompletedNCT02431091
Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder
Evaluation of the Role of Optical Coherence Tomography (OCT) in the Detection of HIV-associated Neurocognitive Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Centre Hospitalier Universitaire Saint Pierre · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the sensitivity and specificity of the use of optical coherence tomography to detect HIV-associated neurocognitive disorder compared to MRI and usual cognitive screening tools.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Optical Coherence Tomography | Optical Coherence Tomography provides a non invasive evaluation of the thickness of different layers of the retina |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2015-04-30
- Last updated
- 2022-03-31
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02431091. Inclusion in this directory is not an endorsement.